Kerr J W, Govindaraj M, Patel K R
Br Med J. 1970 Apr 18;2(5702):139-41. doi: 10.1136/bmj.2.5702.139.
Twenty patients with extrinsic type bronchial asthma are shown to have a significant fall in vital capacity (V.C.) and forced expiratory volume in 1 second (F.E.V.(1)) after an intravenous infusion of 50mug. of histamine dihydrochloride. In 10 of these subjects the fall in V.C. and F.E.V.(1) produced by intravenous histamine is inhibited by the alpha-receptor blocking drugs phentolamine and phenoxybenzamine injected before the histamine test. The inhalation of disodium cromoglycate in 10 subjects is also shown to inhibit the fall in V.C. and F.E.V.(1) produced by the intravenous infusion of histamine. It is suggested that bronchial smooth muscle in asthmatic subjects has alpha-adrenergic receptor sites, and that a possible mechanism for the action of disodium cromoglycate is that it stabilizes the cell membrane, thereby altering calcium ion transport.
20名外源性支气管哮喘患者在静脉输注50微克盐酸组胺后,肺活量(V.C.)和一秒用力呼气量(F.E.V.(1))显著下降。在其中10名受试者中,组胺试验前注射的α受体阻断药物酚妥拉明和酚苄明可抑制静脉注射组胺引起的V.C.和F.E.V.(1)下降。10名受试者吸入色甘酸钠二钠也可抑制静脉输注组胺引起的V.C.和F.E.V.(1)下降。提示哮喘患者的支气管平滑肌具有α肾上腺素能受体位点,色甘酸钠二钠作用的一种可能机制是稳定细胞膜,从而改变钙离子转运。